Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Role of interleukin 1 beta in esophageal squamous cell carcinoma.

Chen MF, Lu MS, Chen PT, Chen WC, Lin PY, Lee KD.

J Mol Med (Berl). 2012 Jan;90(1):89-100. doi: 10.1007/s00109-011-0809-4. Epub 2011 Sep 13.

PMID:
21912958
2.

IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus.

Chen MF, Chen PT, Lu MS, Lin PY, Chen WC, Lee KD.

Mol Cancer. 2013 Apr 5;12:26. doi: 10.1186/1476-4598-12-26.

3.

The role of DNA methyltransferase 3b in esophageal squamous cell carcinoma.

Chen MF, Lu MS, Lin PY, Chen PT, Chen WC, Lee KD.

Cancer. 2012 Aug 15;118(16):4074-89. doi: 10.1002/cncr.26736. Epub 2011 Dec 27.

4.
5.

Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma.

Sugimura K, Miyata H, Tanaka K, Hamano R, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Mori M, Doki Y.

Clin Cancer Res. 2012 Sep 15;18(18):5144-53. doi: 10.1158/1078-0432.CCR-12-0701. Epub 2012 Jul 30.

6.

Prognostic impact of tumor IL-6 expression after preoperative chemoradiotherapy in patients with advanced esophageal squamous cell carcinoma.

Yoneda M, Fujiwara H, Furutani A, Ikai A, Tada H, Shiozaki A, Komatsu S, Kubota T, Ichikawa D, Okamoto K, Konishi H, Murayama Y, Kuriu Y, Ikoma H, Nakanishi M, Ochiai T, Otsuji E.

Anticancer Res. 2013 Jun;33(6):2699-705.

PMID:
23749929
7.

Expression of angiostatic platelet factor-4var/CXCL4L1 counterbalances angiogenic impulses of vascular endothelial growth factor, interleukin-8/CXCL8, and stromal cell-derived factor 1/CXCL12 in esophageal and colorectal cancer.

Verbeke H, De Hertogh G, Li S, Vandercappellen J, Noppen S, Schutyser E, El-Asrar AA, Opdenakker G, Van Damme J, Geboes K, Struyf S.

Hum Pathol. 2010 Jul;41(7):990-1001. doi: 10.1016/j.humpath.2009.09.021. Epub 2010 Mar 23.

PMID:
20334899
8.

The predictive role of E2-EPF ubiquitin carrier protein in esophageal squamous cell carcinoma.

Chen MF, Lee KD, Lu MS, Chen CC, Hsieh MJ, Liu YH, Lin PY, Chen WC.

J Mol Med (Berl). 2009 Mar;87(3):307-20. doi: 10.1007/s00109-008-0430-3. Epub 2008 Dec 16.

PMID:
19083192
9.
10.

Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.

Yamamoto H, Vinitketkumnuen A, Adachi Y, Taniguchi H, Hirata T, Miyamoto N, Nosho K, Imsumran A, Fujita M, Hosokawa M, Hinoda Y, Imai K.

Carcinogenesis. 2004 Dec;25(12):2353-60. Epub 2004 Aug 27.

PMID:
15333466
11.

High phosphorylated 4E-binding protein 1 expression after chemoradiotherapy is a predictor for locoregional recurrence and worse survival in esophageal squamous cell carcinoma patients.

Chao YK, Chuang WY, Yeh CJ, Chang YS, Wu YC, Kuo SY, Hsieh MJ, Hsueh C.

J Surg Oncol. 2012 Mar;105(3):288-92. doi: 10.1002/jso.22097. Epub 2011 Sep 19.

PMID:
21932407
12.

Lack of activated Smad2 in transforming growth factor-beta signaling is an unfavorable prognostic factor in patients with esophageal squamous cell carcinoma.

Fukuchi M, Nakajima M, Miyazaki T, Masuda N, Osawa H, Manda R, Tsukada K, Kato H, Kuwano H.

J Surg Oncol. 2006 Jul 1;94(1):51-6.

PMID:
16788944
13.

Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.

Sugiura H, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Mori Y, Ogawa R, Katada T, Harata K, Fujii Y.

Oncol Rep. 2008 Mar;19(3):713-9.

PMID:
18288406
14.

Inhibiting interleukin-19 activity ameliorates esophageal squamous cell carcinoma progression.

Hsing CH, Kwok FA, Cheng HC, Li CF, Chang MS.

PLoS One. 2013 Oct 9;8(10):e75254. doi: 10.1371/journal.pone.0075254. eCollection 2013.

15.

Expression of KIAA0101 protein is associated with poor survival of esophageal cancer patients and resistance to cisplatin treatment in vitro.

Cheng Y, Li K, Diao D, Zhu K, Shi L, Zhang H, Yuan D, Guo Q, Wu X, Liu D, Dang C.

Lab Invest. 2013 Dec;93(12):1276-87. doi: 10.1038/labinvest.2013.124. Epub 2013 Oct 21.

16.

COX2 expression predicts resistance to chemoradiotherapy in esophageal squamous cell carcinoma.

Akutsu Y, Hanari N, Yusup G, Komatsu-Akimoto A, Ikeda N, Mori M, Yoneyama Y, Endo S, Miyazawa Y, Matsubara H.

Ann Surg Oncol. 2011 Oct;18(10):2946-51. doi: 10.1245/s10434-011-1645-z. Epub 2011 Mar 25.

PMID:
21437756
17.

The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma.

Iizuka N, Hirose K, Noma T, Hazama S, Tangoku A, Hayashi H, Abe T, Yamamoto K, Oka M.

Br J Cancer. 1999 Oct;81(3):469-75.

18.

Expression and prognostic value of MG7-Ag in patients with surgically resectable esophageal squamous cell carcinoma.

Zhao Y, Jiang Y, Wang R, Zheng X, Wang X, Jin B, Lu Y, Qiao T, Hong L, Fan D.

Ann Surg Oncol. 2007 Sep;14(9):2621-7. Epub 2007 Jun 15.

PMID:
17570016
19.

Connective tissue growth factor gene expression alters tumor progression in esophageal cancer.

Koliopanos A, Friess H, di Mola FF, Tang WH, Kubulus D, Brigstock D, Zimmermann A, B├╝chler MW.

World J Surg. 2002 Apr;26(4):420-7. Epub 2002 Feb 4.

PMID:
11910473
20.

Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.

Ren HZ, Pan GQ, Wang JS, Wen JF, Wang KS, Luo GQ, Shan XZ.

Dig Dis Sci. 2010 Sep;55(9):2552-60. doi: 10.1007/s10620-009-1065-0. Epub 2010 Jan 27.

PMID:
20108042

Supplemental Content

Support Center